398 related articles for article (PubMed ID: 30098476)
1. Adipokine interactions promote the pathogenesis of systemic lupus erythematosus.
Chougule D; Nadkar M; Venkataraman K; Rajadhyaksha A; Hase N; Jamale T; Kini S; Khadilkar P; Anand V; Madkaikar M; Pradhan V
Cytokine; 2018 Nov; 111():20-27. PubMed ID: 30098476
[TBL] [Abstract][Full Text] [Related]
2. Serum adipokine levels and associations with patient-reported fatigue in systemic lupus erythematosus.
Mahieu MA; Ahn GE; Chmiel JS; Dunlop DD; Helenowski IB; Semanik P; Song J; Yount S; Chang RW; Ramsey-Goldman R
Rheumatol Int; 2018 Jun; 38(6):1053-1061. PubMed ID: 29302804
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
[TBL] [Abstract][Full Text] [Related]
4. Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease.
Wakiya R; Ueeda K; Shimada H; Nakashima S; Kameda T; Miyatake N; Kato M; Miyagi T; Sugihara K; Mizusaki M; Mino R; Kadowaki N; Dobashi H
Clin Rheumatol; 2022 Nov; 41(11):3345-3353. PubMed ID: 35849246
[TBL] [Abstract][Full Text] [Related]
5. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
6. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
7. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
Smykał-Jankowiak K; Niemir ZI; Polcyn-Adamczak M
Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370
[TBL] [Abstract][Full Text] [Related]
8. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
Shang X; Ren L; Sun G; Yu T; Yao Y; Wang L; Liu F; Zhang L; He X; Liu M
Immun Inflamm Dis; 2021 Jun; 9(2):407-418. PubMed ID: 33470559
[TBL] [Abstract][Full Text] [Related]
9. Association of Serum Ferritin Levels with Hematological Manifestations in Systemic Lupus Erythematosus Patients from Western India.
Pradhan V; Pandit P; Rajadhyaksha A; Patwardhan M; Surve P; Kamble P; Lecerf M; Bayry J; Kaveri S; Ghosh K; Nadkar MY
J Assoc Physicians India; 2016 May; 64(5):14-18. PubMed ID: 27735143
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
[TBL] [Abstract][Full Text] [Related]
11. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
[TBL] [Abstract][Full Text] [Related]
12. High serum leptin and adiponectin levels as biomarkers of disease progression in Egyptian patients with active systemic lupus erythematosus.
Kamel SM; Abdel Azeem Abd Elazeem MEMI; Mohamed RA; Kamel MM; Abdel Aleem Abdelaleem EA
Int J Immunopathol Pharmacol; 2023; 37():3946320231154988. PubMed ID: 36718110
[No Abstract] [Full Text] [Related]
13. Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors.
Vadacca M; Margiotta D; Rigon A; Cacciapaglia F; Coppolino G; Amoroso A; Afeltra A
J Rheumatol; 2009 Feb; 36(2):295-7. PubMed ID: 19132788
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of adipokines in systemic lupus erythematosus patients.
Zhang TP; Li HM; Leng RX; Li XP; Li XM; Pan HF; Ye DQ
Cytokine; 2016 Oct; 86():15-20. PubMed ID: 27442006
[TBL] [Abstract][Full Text] [Related]
15. Serum DNase I activity in systemic lupus erythematosus: correlation with immunoserological markers, the disease activity and organ involvement.
Skiljevic D; Jeremic I; Nikolic M; Andrejevic S; Sefik-Bukilica M; Stojimirovic B; Bonaci-Nikolic B
Clin Chem Lab Med; 2013 May; 51(5):1083-91. PubMed ID: 23183758
[TBL] [Abstract][Full Text] [Related]
16. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.
Hasan SI; Mohd Ashari NS; Mohd Daud K; Che Husin CM
Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264
[TBL] [Abstract][Full Text] [Related]
17. Leptin and adiponectin in patients with systemic lupus erythematosus: clinical and laboratory correlations.
Barbosa Vde S; Francescantônio PL; Silva NA
Rev Bras Reumatol; 2015; 55(2):140-5. PubMed ID: 25440710
[TBL] [Abstract][Full Text] [Related]
18. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.
Magro-Checa C; Schaarenburg RA; Beaart HJ; Huizinga TW; Steup-Beekman GM; Trouw LA
Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265
[TBL] [Abstract][Full Text] [Related]
19. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
Tripathy R; Panda AK; Das BK
Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
[TBL] [Abstract][Full Text] [Related]
20. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
Gilliam BE; Ombrello AK; Burlingame RW; Pepmueller PH; Moore TL
Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]